Truvestments Capital LLC Abbott Laboratories Transaction History

Truvestments Capital LLC

$252 Million
Q1 2024

A detailed history of Truvestments Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Truvestments Capital LLC holds 17,418 shares of ABT stock, worth $1.81 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

17,418

Previous 1,401 1143.25%

Holding current value

$1.81 Million

Previous $154,000 1185.06%

% of portfolio

0.78%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $1.75 Million - $1.94 Million	16,017 Added 1143.25%	17,418 $1.98 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $11,544 - $14,131	-128 Reduced 8.37%	1,401 $154,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $158,484 - $190,154	-1,659 Reduced 52.04%	1,529 $148,000
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $183,721 - $204,704	1,823 Added 133.55%	3,188 $347,000
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $15,981 - $18,811	-165 Reduced 10.78%	1,365 $138,000

Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $1,996 - $2,341	-21 Reduced 1.35%	1,530 $168,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $580 - $672	6 Added 0.39%	1,551 $150,000
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $32,458 - $39,231	-318 Reduced 17.07%	1,545 $168,000
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $24,400 - $29,754	-214 Reduced 10.3%	1,863 $221,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $808 - $990	7 Added 0.34%	2,077 $292,000
Q3 2021 Oct 29, 2021	BUY	$116.66 - $129.06 $816 - $903	7 Added 0.34%	2,070 $245,000
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $68,340 - $80,446	-646 Reduced 23.85%	2,063 $239,000
Q1 2021 May 18, 2021	BUY	$108.84 - $128.23 $1,088 - $1,282	10 Added 0.37%	2,709 $325,000
Q4 2020 Feb 17, 2021	SELL	$105.0 - $114.42 $11,550 - $12,586	-110 Reduced 3.92%	2,699 $295,000
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $20,435 - $24,817	-223 Reduced 7.35%	2,809 $305,000
Q2 2020 Aug 06, 2020	SELL	$76.57 - $98.0 $158,806 - $203,252	-2,074 Reduced 40.62%	3,032 $277,000
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $469,830 - $687,020	-7,479 Reduced 59.43%	5,106 $402,000
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $4,789 - $5,331	61 Added 0.49%	12,585 $1.09 Million
Q3 2019 Oct 10, 2019	BUY	$81.84 - $88.74 $77,502 - $84,036	947 Added 8.18%	12,524 $1.05 Million
Q2 2019 Jul 15, 2019	BUY	$72.88 - $85.0 $367,898 - $429,080	5,048 Added 77.32%	11,577 $974,000
Q1 2019 Apr 12, 2019	SELL	$66.22 - $80.06 $372,951 - $450,897	-5,632 Reduced 46.31%	6,529 $522,000
Q3 2018 Oct 22, 2018	BUY	$60.81 - $73.36 $56,006 - $67,564	921 Added 8.19%	12,161 $892,000
Q2 2018 Aug 28, 2018	BUY	$57.57 - $63.54 $647,086 - $714,189	11,240 New	11,240 $686,000

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.

Account

Truvestments Capital LLC Abbott Laboratories Transaction History